【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Fabry Disease 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Fabry Disease 24
Subjects Recruited Over a Period of Time 26
Prominent Sponsors 27
Top Companies Participating in Fabry Disease Therapeutics Clinical Trials 29
Prominent Drug Comparison 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Genzyme Corporation 32
Clinical Trial Overview of Genzyme Corporation 32
Amicus Therapeutics, Inc. 34
Clinical Trial Overview of Amicus Therapeutics, Inc. 34
Shire Plc 35
Clinical Trial Overview of Shire Plc 35
GlaxoSmithKline plc 36
Clinical Trial Overview of GlaxoSmithKline plc 36
Sanofi 37
Clinical Trial Overview of Sanofi 37
Green Cross Corporation 38
Clinical Trial Overview of Green Cross Corporation 38
Shire Human Genetic Therapies, Inc. 39
Clinical Trial Overview of Shire Human Genetic Therapies, Inc. 39
Protalix Ltd. 40
Clinical Trial Overview of Protalix Ltd. 40
Genzyme BV 41
Clinical Trial Overview of Genzyme BV 41
O & O Alpan, LLC 42
Clinical Trial Overview of O & O Alpan, LLC 42
GlaxoSmithKline Inc. 43
Clinical Trial Overview of GlaxoSmithKline Inc. 43
ISU ABXIS Co.,Ltd. 44
Clinical Trial Overview of ISU ABXIS Co.,Ltd. 44
GlaxoSmithKline AG 45
Clinical Trial Overview of GlaxoSmithKline AG 45
Abbott Laboratories 46
Clinical Trial Overview of Abbott Laboratories 46
Clinical Trial Overview of Top Universities / Institutes / Hospitals 47
University of Alabama at Birmingham 47
Clinical Trial Overview of University of Alabama at Birmingham 47
Baylor Research Institute 48
Clinical Trial Overview of Baylor Research Institute 48
University of Rostock 49
Clinical Trial Overview of University of Rostock 49
University of Minnesota 50
Clinical Trial Overview of University of Minnesota 50
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences 51
Clinical Trial Overview of Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences 51
Canadian Fabry Research Consortium 52
Clinical Trial Overview of Canadian Fabry Research Consortium 52
Assistance Publique – Hopitaux de Paris 53
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 53
Wolfson Medical Center 54
Clinical Trial Overview of Wolfson Medical Center 54
Academic Medical Centre 55
Clinical Trial Overview of Academic Medical Centre 55
Mario Negri Institute for Pharmacological Research 56
Clinical Trial Overview of Mario Negri Institute for Pharmacological Research 56
Danish Pain Research Center 57
Clinical Trial Overview of Danish Pain Research Center 57
Ghent University Hospital 58
Clinical Trial Overview of Ghent University Hospital 58
University of Zurich 59
Clinical Trial Overview of University of Zurich 59
Shaare Zedek Medical Center 60
Clinical Trial Overview of Shaare Zedek Medical Center 60
University Hospital, Bordeaux 61
Clinical Trial Overview of University Hospital, Bordeaux 61
Medical University of Vienna 62
Clinical Trial Overview of Medical University of Vienna 62
The Ohio State University 63
Clinical Trial Overview of The Ohio State University 63
Cedars-Sinai Medical Center 64
Clinical Trial Overview of Cedars-Sinai Medical Center 64
Centre Hospitalier Universitaire de Nice 65
Clinical Trial Overview of Centre Hospitalier Universitaire de Nice 65
Five Key Clinical Profiles 66
Appendix 82
Abbreviations 82
Definitions 82
Research Methodology 83
Secondary Research 83
About GlobalData 84
Contact Us 84
Disclaimer 84
Source 85
【レポート販売概要】
■ タイトル：Fabry Disease：グローバル臨床試験レビューH1, 2013■ 英文：Fabry Disease Global Clinical Trials Review, H1, 2013
■ 発行日：2013年2月15日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160390
■ 調査対象地域：グローバル
- バス高速輸送システム（BRT）の世界市場：ディーゼルBRT、代替燃料BRTAbout BRT systems BRT systems are highly sophisticated bus-based transit systems that are meant to deliver efficient, rapid, and cost-effective high capacity public transportation services. Apart from vehicles, BRT systems also comprise right-of-way lanes, on-board ITS, and stations. They use hi-tech communication technologies to track the location of vehicles and provide timely information to pas …
- 水溶性フィルムの世界市場：キシラン、PVA/PVOH水溶性フィルムWater soluble (PVA/PVOH) film is commercially made from polyvinyl alcohol resins and due to its water soluble property, is widely used for water soluble small dose packaging of detergents, agrochemicals, water treatment chemicals, dyes, and food. Apart from these applications, water soluble (PVA/PVOH) film is used in embroidery and laundry bag manufacturing. North America is the global leader of t …
- 2014年戦略提言：ドイツの免疫タンパク質検査市場This new 236-page report from Venture Planning Group provides analysis of the German immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by market segment for the follow assays:C3C4Free Light ChainsHaptoglobinIgAIgE Specific Ig …
- 自動光学検査（AOI）システムの世界市場予測（～2024年）“Automated optical inspection system market to exhibit significant growth during 2018–2024”The automated optical inspection (AOI) system market is estimated to grow from USD 444 million by 2018 to USD 1,641.0 million by 2024, at a CAGR of 24.3% during 2018–2024. The key factors driving the growth of the market include growing demand for consumer electronics, increasing need for high-quality electr …
- ステビアの世界市場2016-2020About Stevia Stevia, also known as stevia rebaudiana, is a natural and calorie-free plant-derived sweetener used as a sugar substitute in food, beverages, and other applications. The stevia plant contains sweet compounds called steviol glycosides. It is 250-300 times sweeter than sugar. Technavio’s analysts forecast the global stevia market to grow at a CAGR of 8.82% during the period 2016-2020. [ …
- 医療バイオメトリクスの世界市場規模・予測：技術別（顔認識、指紋認識、虹彩認識、静脈認証、掌形認識、行動認識）、セグメント予測The global healthcare biometrics market is expected to reach USD 11.7 billion by 2024, according to a new report by Grand View Research, Inc. The demand for biometric systems in the healthcare market is expected to surge due to the rising cases of medical identity thefts, the most predominant form of healthcare fraud jeopardizing patient health, and the resultant government initiatives favoring di …
- 圧力発信器の世界市場2017-2021ABSTRACTAbout Pressure Transmitters Pressure transmitters are devices that are used to measure the pressure and flow rate of fluids and gases. These are mainly used in industrial machinery to monitor the pressure levels. These devices help in preventing any accidents that might occur due to high pressure. These devices alert/warn the users about the increase in pressure. Pressure transmitters are …
- 世界のIAM（アイデンティティー&アクセス管理）市場Organizations are transitioning from traditional Identity (ID) management to cloud ID management, as the need for affordable and manageable identity management solutions and popularity of cloud models are increasing. Traditionally, most of the companies have on-premise Identity and Access Management (IAM) solutions, but with an increasing trust in cloud-based services, the market for IAM across sm …
- 世界の肝炎診断検査（医療機器）市場：サプライヤーシェア及び市場予測The report presents a detailed analysis of the Hepatitis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, …
- Nexen Inc.：石油・ガスバリューチェーン分析レポート2013Nexen Inc. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Nexen Inc." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Nexen Inc.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the company’s business st …
- 世界のシール及びガスケット市場（2011-2015）TechNavio's analysts forecast the Global Seal and Gasket market to grow at a CAGR of 4.40 percent over the period 2011-2015. One of the key factors contributing to this market growth is the need to enhance engineering equipment's performance. The Global Seal and Gasket market has also been witnessing the increasing adoption of on-board condition monitoring with advanced support systems. However, t …
- 世界主要国の敗血症検査（医療機器）市場：サプライヤーシェア及び市場予測The report presents a detailed analysis of the Septicemia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Septicemia definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Co …
- ETFE（エチレン-テトラフルオロエチレン共重合体）の世界市場The report covers the global ETFE market and also divides it on the basis of type, technology, applications, and region. The market data for these ETFE types are given with respect to volume (tons) and value ($million). The global market size by value of ETFE was estimated to be $462.14 million in 2014 and is projected to grow at a CAGR of about 9.91% between 2014 and 2019. The data mentioned in t …
- クリーンラベル成分の世界市場：種類別（自然色、天然香料、デンプン＆甘味料、天然防腐剤、その他）、用途別（飲料、ベーカリー＆菓子、ソース＆調味料、乳製品＆冷凍デザート、その他の加工食品）、フォーム別（粉末、液体）The clean label ingredients market was valued at $38.8 billion in 2018, and is projected to reach $64.1 billion by 2026, growing at a CAGR of 6.8% from 2019 to 2026. Clean label products are those which are made by using very few ingredients and are natural or organic. Although organic farming is old term, clean label ingredients is a new trend in the food & beverage industry. Clean label does not …
- Tuberculosis：グローバル臨床試験レビューH2, 2013Tuberculosis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Tuberculosis Global Clinical Trials Review, H2, 2013" provides data on the Tuberculosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tuberculosis. It includes an overview of the trial numbers and their recruitment status as per the sit …
